Shyamali Ghosh

Author PubWeight™ 90.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007 19.18
2 A common inversion under selection in Europeans. Nat Genet 2005 13.66
3 A common variant associated with prostate cancer in European and African populations. Nat Genet 2006 13.47
4 A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007 13.28
5 Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 2007 12.65
6 Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002 7.40
7 Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 2008 6.10
8 Multiple novel transcription initiation sites for NRG1. Gene 2004 1.31
9 Sequences from first settlers reveal rapid evolution in Icelandic mtDNA pool. PLoS Genet 2009 1.03
10 A statistical approach to identify ancient template DNA. J Mol Evol 2007 1.02
11 Studies with an orally bioavailable alpha V integrin antagonist in animal models of ocular vasculopathy: retinal neovascularization in mice and retinal vascular permeability in diabetic rats. J Pharmacol Exp Ther 2007 0.91
12 Nonpeptide urotensin-II receptor antagonists: a new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunits. J Med Chem 2009 0.90
13 Phenylpiperidine-benzoxazinones as urotensin-II receptor antagonists: synthesis, SAR, and in vivo assessment. Bioorg Med Chem Lett 2007 0.77
14 Piperidine-containing beta-arylpropionic acids as potent antagonists of alphavbeta3/alphavbeta5 integrins. Bioorg Med Chem Lett 2004 0.75
15 Suzuki-Miyaura approach to JNJ-26076713, an orally active tetrahydroquinoline-containing alphaVbeta3/alphaVbeta5 integrin antagonist. enantioselective synthesis and stereochemical studies. J Org Chem 2008 0.75